The company issued high-yield senior notes due 2029 in the Rule 144A / Regulation S offering

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A / Regulation S offering by Option Care Health, Inc. of $500 million of its 4.375% senior notes due 2029.

Option Care and wholly owned subsidiaries, a company headquartered in Bannockburn, Illinois, is the largest independent provider of home and alternate site infusion services through its national network of 145 locations in 45 states. Option Care Health draws on nearly 40 years of clinical care experience to offer patient-centered, cost-effective infusion therapy. Option Care’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. Option Care Health provides pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings.

The Davis Polk capital markets team included partner Derek Dostal and associates Hillary A. Coleman and Brad Larkin. Partner Michael Farber and associate Eitan Ulmer provided tax advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post